Cargando…

Glycemic Effects and Safety of L-Glutamine Supplementation with or without Sitagliptin in Type 2 Diabetes Patients—A Randomized Study

BACKGROUND AND AIMS: L-glutamine is an efficacious glucagon-like peptide (GLP)-1 secretagogue in vitro. When administered with a meal, glutamine increases GLP-1 and insulin excursions and reduces postprandial glycaemia in type 2 diabetes patients. The aim of the study was to assess the efficacy and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Samocha-Bonet, Dorit, Chisholm, Donald J., Gribble, Fiona M., Coster, Adelle C. F., Carpenter, Kevin H., Jones, Graham R. D., Holst, Jens J., Greenfield, Jerry R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4239068/ https://www.ncbi.nlm.nih.gov/pubmed/25412338 http://dx.doi.org/10.1371/journal.pone.0113366

Ejemplares similares

l-Glutamine and Whole Protein Restore First-Phase Insulin Response and Increase Glucagon-Like Peptide-1 in Type 2 Diabetes Patients
por: Samocha-Bonet, Dorit, et al.
Publicado: (2015)

Effects of Intraduodenal Glutamine on Incretin Hormone and Insulin Release, the Glycemic Response to an Intraduodenal Glucose Infusion, and Antropyloroduodenal Motility in Health and Type 2 Diabetes
por: Chang, Jessica, et al.
Publicado: (2013)

Obesity and Insulin Resistance Are Inversely Associated with Serum and Adipose Tissue Carotenoid Concentrations in Adults
por: Harari, Ayelet, et al.
Publicado: (2020)

Skeletal muscle and plasma lipidomic signatures of insulin resistance and overweight/obesity in humans
por: Tonks, Katherine T., et al.
Publicado: (2016)

Metabolomics and Lipidomics Signatures of Insulin Resistance and Abdominal Fat Depots in People Living with Obesity
por: Koay, Yen Chin, et al.
Publicado: (2022)

Longitudinal Changes in Insulin Resistance in Normal Weight, Overweight and Obese Individuals
por: Tang, Alice, et al.
Publicado: (2019)

Effects of Glutamine on Gastric Emptying of Low- and High-Nutrient Drinks in Healthy Young Subjects—Impact on Glycaemia
por: Du, Yang T., et al.
Publicado: (2018)

The Effect of Buffering High Acid Load Meal with Sodium Bicarbonate on Postprandial Glucose Metabolism in Humans—A Randomized Placebo-Controlled Study
por: Kozan, Pinar, et al.
Publicado: (2017)

MON-LB113 Insulin Resistance in Type 1 Diabetes Managed With Metformin (INTIMET): Rationale and Study Design of a Randomised Placebo-Controlled Trial
por: Snaith, Jennifer R, et al.
Publicado: (2020)

Segregation of a Latent High Adiposity Phenotype in Families with a History of Type 2 Diabetes Mellitus Implicates Rare Obesity-Susceptibility Genetic Variants with Large Effects in Diabetes-Related Obesity
por: Jenkins, Arthur B., et al.
Publicado: (2013)

Muscle Sympathetic Nerve Activity Is Associated with Liver Insulin Sensitivity in Obese Non-Diabetic Men
por: Chen, Daniel L. T., et al.
Publicado: (2017)

Overfeeding Reduces Insulin Sensitivity and Increases Oxidative Stress, without Altering Markers of Mitochondrial Content and Function in Humans
por: Samocha-Bonet, Dorit, et al.
Publicado: (2012)

Short-Term Overfeeding May Induce Peripheral Insulin Resistance Without Altering Subcutaneous Adipose Tissue Macrophages in Humans
por: Tam, Charmaine S., et al.
Publicado: (2010)

Combination Therapy with an SGLT2 Inhibitor as Initial Treatment for Type 2 Diabetes: A Systematic Review and Meta-Analysis
por: Milder, Tamara Y., et al.
Publicado: (2019)

Sitagliptin Successfully Ameliorates Glycemic Control in Werner Syndrome With Diabetes
por: Kitamoto, Takumi, et al.
Publicado: (2012)

Effects of sitagliptin beyond glycemic control: focus on quality of life
por: Sakamoto, Yoshiko, et al.
Publicado: (2013)

Glutamine supplementation
por: Wernerman, Jan
Publicado: (2011)

The Role of Diet in the Pathogenesis and Management of Inflammatory Bowel Disease: A Review
por: Wark, Gabrielle, et al.
Publicado: (2020)

The Role of the Gastrointestinal Microbiome in Liver Disease
por: Shalaby, Nicholas, et al.
Publicado: (2023)

How Sweet It Is: Intestinal Sweet Taste Receptors in Type 2 Diabetes
por: Greenfield, Jerry R., et al.
Publicado: (2013)

Metabolically Protective Cytokines Adiponectin and Fibroblast Growth Factor-21 Are Increased by Acute Overfeeding in Healthy Humans
por: Heilbronn, Leonie K., et al.
Publicado: (2013)

Sitagliptin added to voglibose monotherapy improves glycemic control in patients with type 2 diabetes
por: Tajima, Naoko, et al.
Publicado: (2013)

The effect of encapsulated glutamine on gut peptide secretion in human volunteers
por: Meek, Claire L., et al.
Publicado: (2016)

Glutamine and glutamate supplementation raise milk glutamine concentrations in lactating gilts
por: Manso, Helena Emilia CCC, et al.
Publicado: (2012)

Rationale and design of a randomised controlled trial testing the effect of personalised diet in individuals with pre-diabetes or type 2 diabetes mellitus treated with metformin
por: Htet, Thaw D, et al.
Publicado: (2020)

Endogenous glutamine production in critically ill patients: the effect of exogenous glutamine supplementation
por: Mori, Maiko, et al.
Publicado: (2014)

Glutamine Supplementation in Sick Children: Is It Beneficial?
por: Mok, Elise, et al.
Publicado: (2011)

Glutamine supplementation to critically ill patients?
por: Wernerman, Jan
Publicado: (2014)

Glutamine Supplementation: The Pendulum Keeps on Swinging
por: Todi, Subhash
Publicado: (2019)

Sitagliptin, sitagliptin and metformin, or sitagliptin and amitriptyline attenuate streptozotocin-nicotinamide induced diabetic neuropathy in rats
por: Sharma, Ashish Kumar, et al.
Publicado: (2012)

Sitagliptin-Associated Angioedema
por: Gosmanov, Aidar R., et al.
Publicado: (2012)

The impact of glutamine supplementation on the symptoms of ataxia-telangiectasia: a preclinical assessment
por: Chen, Jianmin, et al.
Publicado: (2016)

Preliminary Study Characterizing the Use of Sitagliptin for Glycemic Control in Healthy Beagle Dogs with Normal Gluco-Homeostasis
por: ODA, Hitomi, et al.
Publicado: (2014)

Efficacy of glutamine dipeptide-supplemented total parenteral nutrition in critically ill patients: a prospective, double-blind randomized trial
por: Grau, TG, et al.
Publicado: (2008)

Erratum to: The impact of glutamine supplementation on the symptoms of ataxia-telangiectasia: a preclinical assessment
por: Chen, Jianmin, et al.
Publicado: (2017)

Glutamine supplementation in the critically ill: friend or foe?
por: Oudemans-van Straaten, Heleen M, et al.
Publicado: (2014)

Enteral glutamine supplementation in critically ill patients
por: Tian, Xu, et al.
Publicado: (2015)

How to understand the results of studies of glutamine supplementation
por: Wernerman, Jan
Publicado: (2015)

Role of parenteral glutamine supplementation on patient outcome in the surgical ICU
por: Aboelmagd, R, et al.
Publicado: (2009)

Impact of glycemic control with sitagliptin on the 2-year progression of arterial stiffness: a sub-analysis of the PROLOGUE study
por: Tomiyama, Hirofumi, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_oo80b1pi1okgfsac3hgjm89kjk